uniQure Archives

Latest Posts

News and Trends 11 Jul 2016

How to build a Successful Biotech company in Europe with Joern Aldag

Joern Aldag is one of the impressive Biotech leaders in Europe. Hearing him at our Refresh conference made me think of a new type of article we could publish: a…

July 11, 2016 - 6 minutesmins - By Philip Hemme

News and Trends 6 May 2016

This Dutch Gene Therapy is on the shelf and seems to Work. But nobody is buying…

uniQure's Glybera was approved in Europe in 2012, making it the first gene therapy on the market in the West. But so far this €1M therapy has only been bought…

May 6, 2016 - 3 minutesmins - By Denise Neves Gameiro

biotech nasdaq stock top biopharma finance 2016

News and Trends 23 Feb 2016

7 Trendy European Biotechs Listed on the NASDAQ in 2016

Here are 7 European Biotechs listed on the NASDAQ we thought were worth mentioning in more depth; location, market cap and brief financial and R&D backgrounds. NASDAQ is the second-largest Stock…

February 23, 2016 - 6 minutesmins - By Philip Hemme

News and Trends 6 Nov 2015

Biotech of the Week: Synpromics, the Scottish company enabling precise Gene Expression

This week we leave the wonderful weather of Mallorca and head North, through France, England and across Hadrian's Wall where we land in the capital city of Scotland, Edinburgh. This…

November 6, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 22 Sep 2015

UniQure’s cure for rare Lysosomal disease ready for phase III trial

UniQure from the Netherlands has promising results for its enzyme replacement therapy phase Ib/II trial targeting a rare Lysosomal disease. This has granted fast-track approval to launch its phase III…

September 22, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 8 May 2015

GSK sparks off the Gene Therapy resurgence

GlaxoSmithKline has become the first big pharma company to file a gene therapy approval case to the European Medicines Agency (EMA). The therapy, developed in collaboration with San Raffaele Hospital and the Telethon…

May 8, 2015 - 4 minutesmins - By Joachim Eeckhout

News and Trends 7 Apr 2015

A New Key Strategic Collaboration Between BMS and UniQure

Last month, Bristol-Myers Squibb (BMS) and UniQure, the Dutch pioneer in human gene therapy, were at the forefront of the scene after having agreed on two collaborations, respectively, an agreement between Bavarian Nordic…

April 7, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 5 Mar 2015

Synpromics and UniQure, new Collaboration in Gene Therapy.

Synpromics has formed a collaboration with uniQure, the Dutch pioneer in human gene therapy, to develop synthetic promoters with specific application in the delivery of gene therapies to liver. Synpromics, a…

March 5, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 20 Aug 2014

uniQure acquires the gene therapy start-up InoCard

uniQure, a leader in human gene therapy, today announced the acquisition of InoCard GmbH, an innovative, early-stage biotechnology company focused on the development of gene therapy approaches for cardiac disease.…

August 20, 2014 - 3 minutesmins - By Joachim Eeckhout

News and Trends 1 Dec 2014

The First Gene Therapy Drug Will Be Sold at Record €1,1M Price

What could you buy with €1,1M euros? A house? Or a single prescription for a new drug... The first gene therapy drug "Glybera" is set to go on sale in Germany with…

December 1, 2014 - 3 minutesmins - By Julie Lellouche

News and Trends 12 Aug 2015

A Tale of Love for UniQure and Bristol-Myers Squibb

In May, Bristol-Myers Squibb (BMS) nailed down the exclusive access to uniQure's gene therapy platform to treat cardiovascular diseases. Everything seems to work out fine as BMS paid $53M (€47M)…

August 12, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 28 Aug 2015

FDA shelves UniQure’s Glybera – will the Gene therapy once reach the US market?

The €1.1M drug Glybera was the first gene therapy on the European market. UniQure wants to sell it in the US too, but the FDA makes it much more difficult…

August 28, 2015 - 2 minutesmins - By Philip Hemme

Report: new Frontiers in Vaccinology

Listen to our podcast

View all sectors A-Z

Power your event with partnering to deliver attendee ROI. Learn more!

View all companies A-Z

Partner with world-leading academics working on sustainable materials R&D

View all countries A-Z

Report: The European Biotech Startup Ecosystem

Subcribe to our newsletter

Learn more about Inpart, the leading platform for biopharma partnering